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A B S T R A C T
Hepatocellular adenoma (HCA) is a benign liver tumor most frequently occurring in women using oral con-
traception. HCA develops in normal or nearly normal livers and is extremely rare in cirrhosis. The authors
present magnetic resonance imaging and histopathologic ﬁndings in a 57-year-old man with liver cirrhosis and
hepatic adenomatosis.
As the diﬀerentiation between HCA and hepatocellular carcinoma (HCC) can be diﬃcult with imaging, we
would like to highlight the importance of ancillary ﬁndings such as the presence of iron on MRI, which can be
observed in HCA.
1. Introduction
Hepatocellular adenoma (HCA) is a benign liver tumor most fre-
quently occurring in women using oral contraception. HCA develops in
normal or nearly normal livers and is extremely rare in cirrhosis. Here,
we report a case of a patient who has undergone abdominal magnetic
resonance imaging (MRI) with the incidental ﬁnding of hepatic ade-
nomatosis (HA) in the setting of liver cirrhosis.
1.1. Case
A 57-year-old man with abdominal pain was referred to our hos-
pital. His medical history included alcohol abuse, tobacco use and
elevated BMI (27.4 kg/m2). He had no history of diabetes or anabolic
steroid use. The physical exam revealed no stigmata of advanced liver
disease.
Laboratory tests showed elevated gamma-glutamyltransferase
(1466 U/l) and alkaline phosphatase (211 U/l); aspartate transaminase,
alanine transaminase, international normalized ratio, albumin, bilir-
ubin, and alpha-fetoprotein were normal. Viral hepatitis serologies
were negative.
MRI of the abdomen revealed a liver with nodular surface compa-
tible with cirrhosis. There were multiple (> 10) non-fat containing liver
lesions measuring up to 5 cm, appearing hyper- or isointense on pre-
contrast fat suppressed T1-weighted imaging (T1WI), mildly hyper-,
iso- or hypointense on fat suppressed T2WI with intense enhancement
on T1WI obtained during the arterial phase after injection of a gado-
linium-based contrast agent (gadopentetate dimeglumine, Magnevist,
Bayer Healthcare) with washout on portal venous phase and a pseudo-
capsule. Some of these lesions showed signal intensity drop on in-phase
compared to out-of-phase images, indicating iron content (Fig. 1). No
vascular invasion was identiﬁed. There were no signs of portal hy-
pertension. The lesions were interpreted as multifocal HCC. After an
inconclusive ﬁne needle aspiration, a laparoscopic surgical resection of
two lesions revealed HCAs with positive serum amyloid A (SAA) and C-
reactive protein (CRP) on immunohistochemical stains (Fig. 2). The β-
catenin stain was negative. There was background liver cirrhosis, pre-
sumed to be due to alcohol abuse. Follow-up computed tomography
(CT) 6 months later showed stable remaining lesions.
2. Discussion
HCA develops in normal or nearly normal livers and is extremely
rare in cirrhosis. The predisposing factors for developing HCA include
excessive hormonal or metabolic exposures, such as oral contraceptives,
anabolic steroids, glycogen storage disease, and type 2 diabetes. Case-
reports of HCA have been reported in cardiac cirrhosis [1] and in ﬁ-
brosis without known risk factors of HCA [2], all in male patients, as in
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our case.
Whereby HCA may contain iron, it is very unusual for HCC [3]. HCA
may lack portal venous inﬂow and thus can be hypervascular on arterial
phase on CT or MRI. It is often diﬃcult to diﬀerentiate between HCA
and HCC on imaging, due to overlapping appearances, and HCC is the
main diagnosis to consider in cirrhosis.
Liver speciﬁc gadolinium based contrast agents [such as gadobenate
disodium (Gd- BOPTA, Multihance®) and gadoxetate disodium (Gd-
EOB-DTPA), Primovist or Eovist®] facilitate the diﬀerentiation of HCA
from FNH [4]. While the majority of FNHs shows an equal or stronger
OATP1B3 expression relative to the surrounding liver with an iso-/
hyperintensity in the hepatobiliary phase of gadoxetic acid-enhanced
Fig. 1. Contrast-enhanced magnetic resonance imaging in a 57-year-old patient with alcoholic cirrhosis shows multiple mildly T1 hyperintense lesions in the right and left hepatic lobes
(arrows) on pre-contrast T1-weighted images (A, D at diﬀerent levels) with enhancement on subtracted arterial phase images (B, E) and washout on the subtracted portal venous phase
images with pseudo-capsule enhancement (C, F). The lesion in segment III (seen on A, B, C, G, H, I) is hypointense on T2-weighted fat suppressed image (G) and shows signal drop on in-
phase (H) compared to out-of-phase images (I), indicating iron content. The lesion in segment III was resected. Note liver surface nodularity compatible with cirrhosis.
Fig. 2. Histopathologic images of resected hepatocellular adenoma show: (A) on H& E stain (x40), monotonous hepatocytes without atypia, and absence of portal tracts. (B) on H& E
stain (x100) the hepatocytes are arranged in two cell-thick plates. (C) on Trichrome stain (x20), cirrhotic nodules encircled by ﬁbrous septa (arrows), (D) on Perl stain (x100) coarse iron
granules in the adenoma, but not in the surrounding liver. The adenoma is diﬀusely and strongly positive for CRP (immunostain, x20) (E) with patchy serum amyloid A reactivity
(immunostain, x20) (F).
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MRI [5,6], most HCAs have a decreased expression of OATP1B3 re-
sulting in an hypointense signal on delayed hepatobiliary phase images
[7,8]. Diﬀusion-weighted (DW) MRI can be used for liver lesion char-
acterization, with better results compared with T2-weighted imaging
[9–12] and with potential additional value to contrast-enhanced se-
quences. HCAs, however, have intermediate ADC values that can
overlap with those of malignant lesions and normal liver parenchyma
[13–16]. As DW MRI is a marker of cellularity HCAs may sometimes
display restricted diﬀusion. On the other hand, necrotic malignant le-
sions can demonstrate high ADC values.
Using molecular markers and immunohistochemistry, HCAs can be
classiﬁed in eight main subtypes: hepatocyte nuclear factor-1α
(HNF1α)-mutated, SAA/CRP-positive inﬂammatory HCA (IHCA), β-
catenin exon 7/8, β-catenin exon 3, mixed bex7,8 IHCA, mixed bex3
IHCA, sonic hedgehog and unclassiﬁed [17]. HCAs in men were shown
to be usually SAA/CRP-positive, occur singly, and arise from factors
also found in development of HCC in non-cirrhotic liver such as alcohol
use, tobacco use and elevated BMI [18]. Our patient was SAA/CRP-
positive, similar to a prior report [2] and had HA. However, SAA or CRP
expression is not speciﬁc for IHCA, these proteins are known to be
produced by hepatocytes and may be overexpressed in cirrhotic nodules
under local or systemic inﬂammatory conditions [19].
The estimated risk for malignant transformation of HCA is between
4% and 8% [20]. All subtypes of HCA may demonstrate borderline
features of typical foci of HCC. However, the β-catenin mutated HCA
and mixed bex3IHCA subgroups are the most prone to malignant
transformation [21–23].
During hepatocarcinogenesis, iron may accumulate in low-grade
dysplastic nodules (DNs) and in some high-grade DNs. These nodules
containing an iron deposit are referred to as ‘siderotic nodules’. In he-
patocytes of siderotic nodules, the iron transporter system, such as the
transferrin transporter, are upregulated [24]. However, as these no-
dules progress into HCCs, the iron-transportation system also alters, and
iron utilization increases, thus causing iron deﬁciency in HCCs [25].
However, HCAs may deposit iron [26–28] and Cheng et al. [27] even
proposed the term siderotic hepatic adenoma in these cases.
3. Conclusion
Our case supports the existence of HCA/HA in the setting of cir-
rhosis. As the diﬀerentiation between HCA and HCC is often diﬃcult
with imaging, it is advisable to perform a short-term follow-up imaging
and/or tissue sampling for a deﬁnitive diagnosis.
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